Product Liability & Mass Torts Digest
Topics
Contributors
Sort by:
1 result
August 18, 2020
|8 min read
Tenth Circuit Reverses Preemption Dismissal in Biologic Injectable Drug MDL
The doctrines of implied preemption and agency deference continue to develop with the Tenth Circuit’s recent decision in In re MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practice Litigation.
About This Blog
Winston & Strawn’s Product Liability & Mass Torts Digest provides updates, insights, and practical tips on a full spectrum of issues related to product liability and mass torts litigation.
